Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine for dyspnea in interstitial lung disease (JORTC-PAL15)
jRCTs051190030Phase 2Recruiting
- Sponsor
- Grants-in-aid for Young Scientists
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in interstitial lung disease (ILD) comparing Morphine arm with Placebo arm (2 arms). Started Sep 2019; status: recruiting.
02
Drugs
morphine
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on jRCTs051190030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190030.